161 related articles for article (PubMed ID: 25654087)
1. The effect of CYP, GST, and SULT polymorphisms and their interaction with smoking on the risk of hepatocellular carcinoma.
Boccia S; Miele L; Panic N; Turati F; Arzani D; Cefalo C; Amore R; Bulajic M; Pompili M; Rapaccini G; Gasbarrini A; La Vecchia C; Grieco A
Biomed Res Int; 2015; 2015():179867. PubMed ID: 25654087
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population.
Boccia S; Sayed-Tabatabaei FA; Persiani R; Gianfagna F; Rausei S; Arzani D; La Greca A; D'Ugo D; La Torre G; van Duijn CM; Ricciardi G
BMC Cancer; 2007 Nov; 7():206. PubMed ID: 17996038
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.
Quiñones L; Lucas D; Godoy J; Cáceres D; Berthou F; Varela N; Lee K; Acevedo C; Martínez L; Aguilera AM; Gil L
Cancer Lett; 2001 Dec; 174(1):35-44. PubMed ID: 11675150
[TBL] [Abstract][Full Text] [Related]
4. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer.
Boccia S; Cadoni G; Sayed-Tabatabaei FA; Volante M; Arzani D; De Lauretis A; Cattel C; Almadori G; van Duijn CM; Paludetti G; Ricciardi G
J Cancer Res Clin Oncol; 2008 Jan; 134(1):93-100. PubMed ID: 17611777
[TBL] [Abstract][Full Text] [Related]
6. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population.
Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
Mol Cell Biochem; 2004 Nov; 266(1-2):1-9. PubMed ID: 15646021
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.
Yu MW; Chiu YH; Yang SY; Santella RM; Chern HD; Liaw YF; Chen CJ
Br J Cancer; 1999 May; 80(3-4):598-603. PubMed ID: 10408872
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma.
Munaka M; Kohshi K; Kawamoto T; Takasawa S; Nagata N; Itoh H; Oda S; Katoh T
J Cancer Res Clin Oncol; 2003 Jun; 129(6):355-60. PubMed ID: 12759747
[TBL] [Abstract][Full Text] [Related]
10. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE
Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720
[TBL] [Abstract][Full Text] [Related]
11. CYP1A1, GSTM1 and GSTT1 genetic polymorphisms and gastric cancer risk among Japanese: A nested case-control study within a large-scale population-based prospective study.
Hidaka A; Sasazuki S; Matsuo K; Ito H; Charvat H; Sawada N; Shimazu T; Yamaji T; Iwasaki M; Inoue M; Tsugane S;
Int J Cancer; 2016 Aug; 139(4):759-68. PubMed ID: 27062139
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population.
Murata M; Watanabe M; Yamanaka M; Kubota Y; Ito H; Nagao M; Katoh T; Kamataki T; Kawamura J; Yatani R; Shiraishi T
Cancer Lett; 2001 Apr; 165(2):171-7. PubMed ID: 11275366
[TBL] [Abstract][Full Text] [Related]
13. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population.
Wang J; Deng Y; Li L; Kuriki K; Ding J; Pan X; Zhuge X; Jiang J; Luo C; Lin P; Tokudome S
Cancer Sci; 2003 May; 94(5):448-52. PubMed ID: 12824892
[TBL] [Abstract][Full Text] [Related]
14. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
15. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
16. CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.
Hamachi T; Tajima O; Uezono K; Tabata S; Abe H; Ohnaka K; Kono S
World J Gastroenterol; 2013 Jul; 19(25):4023-30. PubMed ID: 23840148
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma.
Yu MW; Gladek-Yarborough A; Chiamprasert S; Santella RM; Liaw YF; Chen CJ
Gastroenterology; 1995 Oct; 109(4):1266-73. PubMed ID: 7557094
[TBL] [Abstract][Full Text] [Related]
18. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
19. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case-control study in a Han nationality population in Southern China.
Yang J; Qian LX; Wu HF; Xu ZQ; Sui YG; Wang XR; Zhang W
Int J Urol; 2006 Jun; 13(6):773-80. PubMed ID: 16834659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
